$ROCL
Roth CH Acquisition V Co Stock $rocl

$rocl Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000182912623007606 Filed on November 20, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$471.3K	$908.4K
YoY Change	278.04%	638.92%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$471.3K	$908.4K
YoY Change	278.04%	638.92%
Operating Profit		-$908.4K
YoY Change		638.9%
Interest Expense	$317.6K	$352.3K
YoY Change	-67.83%	-33.13%
% of Operating Profit
Other Income/Expense, Net		$352.3K
YoY Change		-33.13%
Pretax Income	-$153.8K	-$556.1K
YoY Change	-117.82%	-237.66%
Income Tax	$90.83K	$90.04K
% Of Pretax Income
Net Earnings	-$244.6K	-$646.1K
YoY Change	-143.76%	-312.3%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.04	-$0.11
COMMON SHARES
Basic Shares Outstanding	5.847M shares	5.847M
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$200.1K	$112.9K
YoY Change	-99.83%	-99.9%
Cash & Equivalents	$200.1K	$112.9K
Short-Term Investments
Other Short-Term Assets	$17.04M	$26.79M
YoY Change	11241.32%	12793.43%
Inventory
Prepaid Expenses	$62.17K	$76.77K
Receivables
Other Receivables
Total Short-Term Assets	$17.24M	$26.90M
YoY Change	-85.54%	-77.26%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$17.24M	$26.90M
Total Long-Term Assets	$0.00	$0.00
Total Assets	$17.24M	$26.90M
YoY Change	-85.54%	-77.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$2.129M	$1.664M
YoY Change	847.34%	790.73%
Deferred Revenue
YoY Change
Short-Term Debt	$416.8K	$250.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.688M	$2.116M
YoY Change	316.18%	595.64%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.688M	$2.116M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$2.688M	$2.116M
YoY Change	316.18%	595.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.398M	-$1.807M
YoY Change	-532.49%	41101.07%
Common Stock	$334.00	$334.00
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$14.55M	-$1.806M
YoY Change
Total Liabilities & Shareholders Equity	$17.24M	$26.90M
YoY Change	-85.54%	-77.26%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$244.6K	-$646.1K
YoY Change	-143.76%	-312.3%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$90.26K	-$850.7K
YoY Change	209.11%	2093.04%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$10.06M	-$3.080K
YoY Change	31239.91%
Cash From Investing Activities	$10.06M	-$3.080K
YoY Change	31239.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-9.883M	89.23K
YoY Change
NET CHANGE
Cash From Operating Activities	-90.26K	-850.7K
Cash From Investing Activities	10.06M	-3.080K
Cash From Financing Activities	-9.883M	89.23K
Net Change In Cash	87.12K	-764.5K
YoY Change	2904.14%	1870.95%
FREE CASH FLOW
Cash From Operating Activities	-$90.26K	-$850.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001885998
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q4	rocl	Due To Non Redeeming Stockholders Current DueToNonRedeemingStockholdersCurrent		usd
CY2022Q4	rocl	Promissory Note Related Party PromissoryNoteRelatedParty		usd
CY2022Q4	rocl	Exercise Taxes Payable Current ExerciseTaxesPayableCurrent		usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q3	rocl	Change In Fair Value Of Due To Nonredeeming Stockholder ChangeInFairValueOfDueToNonredeemingStockholder		usd
	rocl	Change In Fair Value Of Due To Nonredeeming Stockholder ChangeInFairValueOfDueToNonredeemingStockholder		usd
	rocl	Proceeds From Trust Account To Compensate Expenses ProceedsFromTrustAccountToCompensateExpenses		usd
	rocl	Proceeds From Trust Account In Connection With Redemption ProceedsFromTrustAccountInConnectionWithRedemption		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	rocl	Proceeds From Promissory Note Related Party ProceedsFromPromissoryNoteRelatedParty		usd
	rocl	Payments To Non Redeeming Stockholders PaymentsToNonRedeemingStockholders		usd
	rocl	Payment For Redempton Of Common Stock PaymentForRedemptonOfCommonStock		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	rocl	Excise Taxes On Stock Redemption From Non Cash Financing Activities ExciseTaxesOnStockRedemptionFromNonCashFinancingActivities		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q3	rocl	Excise Taxes On Stock Redemptions ExciseTaxesOnStockRedemptions		usd
CY2022Q3	rocl	Excise Taxes On Stock Redemptions ExciseTaxesOnStockRedemptions		usd
	rocl	Excise Taxes On Stock Redemptions ExciseTaxesOnStockRedemptions		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41105
	dei	Entity Registrant Name EntityRegistrantName	ROTH CH ACQUISITION V CO.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-1229207
	dei	Entity Address Address Line1 EntityAddressAddressLine1	888 San Clemente Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 400
	dei	Entity Address City Or Town EntityAddressCityOrTown	Newport Beach
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92660
	dei	City Area Code CityAreaCode	(949)
	rocl	Basic And Diluted Net Loss Income Per Share Nonredeemable Common Stock BasicAndDilutedNetLossIncomePerShareNonredeemableCommonStock	-0.24
	dei	Local Phone Number LocalPhoneNumber	720-5700
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5847012	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	112941	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	687471	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	76766	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	150250	usd
CY2023Q3	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	26711906	usd
CY2022Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	118377460	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	26901613	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	119215181	usd
CY2023Q3	us-gaap	Assets Assets	26901613	usd
CY2022Q4	us-gaap	Assets Assets	119215181	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	733415	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	224719	usd
CY2023Q3	rocl	Due To Non Redeeming Stockholders Current DueToNonRedeemingStockholdersCurrent	151189	usd
CY2023Q3	rocl	Promissory Note Related Party PromissoryNoteRelatedParty	250000	usd
CY2023Q3	rocl	Exercise Taxes Payable Current ExerciseTaxesPayableCurrent	930108	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	51673	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	421211	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2116385	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	645930	usd
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	26591561	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	117809374	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3336500	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3336500	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3336500	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3336500	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	334	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	334	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	205072	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1806667	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	554471	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-1806333	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	759877	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26901613	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	119215181	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	908357	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	122934	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1293488	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	416559	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-908357	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-122934	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1293488	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-416559	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	343491	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	526853	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2641366	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	697289	usd
CY2023Q3	rocl	Change In Fair Value Of Due To Nonredeeming Stockholder ChangeInFairValueOfDueToNonredeemingStockholder	-8811	usd
	rocl	Change In Fair Value Of Due To Nonredeeming Stockholder ChangeInFairValueOfDueToNonredeemingStockholder	471189	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	352302	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	526853	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2170177	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	697289	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-556055	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	403919	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	876689	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	280730	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	90037	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	99588	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	719832	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	117471	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-646092	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	304331	usd
	us-gaap	Net Income Loss NetIncomeLoss	156857	usd
	us-gaap	Net Income Loss NetIncomeLoss	163259	usd
CY2023Q3	rocl	Basic And Diluted Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption	2510512	shares
CY2022Q3	rocl	Basic And Diluted Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption	11500000	shares
	rocl	Basic And Diluted Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption	7482720	shares
	rocl	Basic And Diluted Weighted Average Shares Outstanding Common Stock Subject To Possible Redemption BasicAndDilutedWeightedAverageSharesOutstandingCommonStockSubjectToPossibleRedemption	11500000	shares
CY2023Q3	rocl	Basic And Diluted Net Loss Income Per Common Share Common Stock Subject To Possible Redemption BasicAndDilutedNetLossIncomePerCommonShareCommonStockSubjectToPossibleRedemption	-0.07	shares
CY2022Q3	rocl	Basic And Diluted Net Loss Income Per Common Share Common Stock Subject To Possible Redemption BasicAndDilutedNetLossIncomePerCommonShareCommonStockSubjectToPossibleRedemption	0.03	shares
	rocl	Basic And Diluted Net Loss Income Per Common Share Common Stock Subject To Possible Redemption BasicAndDilutedNetLossIncomePerCommonShareCommonStockSubjectToPossibleRedemption	0.13	shares
	rocl	Basic And Diluted Net Loss Income Per Common Share Common Stock Subject To Possible Redemption BasicAndDilutedNetLossIncomePerCommonShareCommonStockSubjectToPossibleRedemption	0.02	shares
CY2023Q3	rocl	Basic And Diluted Weighted Average Shares Outstanding Nonredeemable Common Stock BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableCommonStock	3336500
CY2022Q3	rocl	Basic And Diluted Weighted Average Shares Outstanding Nonredeemable Common Stock BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableCommonStock	3336500
	rocl	Basic And Diluted Weighted Average Shares Outstanding Nonredeemable Common Stock BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableCommonStock	3336500
	rocl	Basic And Diluted Weighted Average Shares Outstanding Nonredeemable Common Stock BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableCommonStock	3336500
CY2023Q3	rocl	Basic And Diluted Net Loss Income Per Share Nonredeemable Common Stock BasicAndDilutedNetLossIncomePerShareNonredeemableCommonStock	-0.14
CY2022Q3	rocl	Basic And Diluted Net Loss Income Per Share Nonredeemable Common Stock BasicAndDilutedNetLossIncomePerShareNonredeemableCommonStock	-0.00
	rocl	Basic And Diluted Net Loss Income Per Share Nonredeemable Common Stock BasicAndDilutedNetLossIncomePerShareNonredeemableCommonStock	-0.02
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	759877	usd
CY2023Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	874573	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	708556	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	593860	usd
CY2023Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	729454	usd
CY2023Q2	rocl	Excise Taxes On Stock Redemption ExciseTaxesOnStockRedemption	-930108	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	94393	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-971309	usd
CY2023Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	188932	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-646092	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-1806333	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1122136	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-151738	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	970398	usd
CY2022Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	72983	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	10666	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	908081	usd
CY2022Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	369382	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	304331	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	843030	usd
	us-gaap	Net Income Loss NetIncomeLoss	156857	usd
	us-gaap	Net Income Loss NetIncomeLoss	163259	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2641366	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	697289	usd
	rocl	Changes In Fair Value Of Due To Nonredeeming Stockholders ChangesInFairValueOfDueToNonredeemingStockholders	471189	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-73484	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-130158	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	508696	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	72077	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-369538	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	117471	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1800678	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-214324	usd
	rocl	Proceeds From Trust Account To Compensate Expenses ProceedsFromTrustAccountToCompensateExpenses	1296148	usd
	rocl	Proceeds From Trust Account In Connection With Redemption ProceedsFromTrustAccountInConnectionWithRedemption	93010772	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	94306920	usd
	rocl	Proceeds From Promissory Note Related Party ProceedsFromPromissoryNoteRelatedParty	250000	usd
	rocl	Payments To Non Redeeming Stockholders PaymentsToNonRedeemingStockholders	320000	usd
	rocl	Payment For Redempton Of Common Stock PaymentForRedemptonOfCommonStock	93010772	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-93080772	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-574530	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-214324	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	687471	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	898895	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	112941	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	684571	usd
	rocl	Change In Value Of Common Stock Subject To Possible Redemption ChangeInValueOfCommonStockSubjectToPossibleRedemption	1792959	usd
	rocl	Change In Value Of Common Stock Subject To Possible Redemption ChangeInValueOfCommonStockSubjectToPossibleRedemption	442365	usd
	rocl	Excise Taxes On Stock Redemption From Non Cash Financing Activities ExciseTaxesOnStockRedemptionFromNonCashFinancingActivities	930108	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1089370	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_805_eus-gaap--NatureOfOperations_zC8AzfO1kmt6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0"><b>NOTE 1. <span id="xdx_82C_zFdJseDrpn22">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">Roth CH Acquisition V Co. (the “Company”) was incorporated in Delaware on November 5, 2020. The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with <span id="xdx_901_ecustom--ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum_c20230101__20230930_z1u8UFvyR6W8" style="display: none" title="Number of businesses minimum">1</span> one or more businesses or entities (the “Business Combination”).</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">As of September 30, 2023, the Company had not commenced any operations. All activity through September 30, 2023 related to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and, subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income on marketable securities held in the Trust Account (as defined below).</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">The registration statement for the Company’s Initial Public Offering was declared effective on November 30, 2021. On December 3, 2021, the Company consummated the Initial Public Offering of <span id="xdx_90B_ecustom--UnitsIssuedDuringPeriodSharesNewIssues_c20211201__20211203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zb2ce51T3MF2" title="Number of units sold">11,500,000</span> units (the “Units” and, with respect to the shares of common stock included in the Units sold, the “Public Shares”), which included the full exercise by the underwriters of their over-allotment option in the amount of <span id="xdx_90C_ecustom--UnitsIssuedDuringPeriodSharesNewIssues_c20211201__20211203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zeYTOrCb8jK8" title="Number of units sold">1,500,000</span> Units, at $<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20211203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zjZTCzLOOQm6" title="purchase price, per Unit">10.00</span> per Unit, generating gross proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20211201__20211203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zVtjMeH7ipWj" title="Proceeds from issuance initial public offering">115,000,000</span>, which is described in Note 3.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20211203__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Sale of private placement units (in shares)">461,500</span> units (the “Private Units”) at a price of $<span id="xdx_90A_ecustom--ClassOfWarrantOrRightPriceOfWarrantsOrRights_iI_c20211203__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z2zLS3Nz3lHg" title="Price of per Unit">10.00</span> per Private Unit in a private placement to certain of the Company’s initial stockholders, generating gross proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfWarrants_c20211201__20211203__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zWGT0E3fzKa9" title="Gross proceeds">4,615,000</span>, which is described in Note 4.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">Transaction costs amounted to $<span id="xdx_907_ecustom--TransactionCosts_iI_c20230930_zU7xrVxiF0O8" title="Transaction costs">1,625,220</span>, consisting of $<span id="xdx_903_ecustom--SaleOfStockUnderwritingFees_iI_c20230930_zRYZhVrjLaxj" title="Underwriting fees">1,150,000</span> of underwriting fees, and $<span id="xdx_905_ecustom--SaleOfStockOtherOfferingCosts_iI_c20230930_z98Xq49ADL5a" title="Other offering costs">475,220</span> of other offering costs.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">Following the closing of the Initial Public Offering on December 3, 2021, an amount of $<span id="xdx_909_ecustom--PaymentsForInvestmentOfCashInTrustAccount_c20211201__20211203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zIhU24z7rEFb" title="Net proceeds of the sale of the Units">116,725,000</span> ($<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20211203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zO0LKZe87Hxj" title="purchase price, per Unit">10.15</span> per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Units was placed in a trust account (the “Trust Account”), located in the United States and held in cash items or invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the proceeds from the Trust Account, as described below.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination having an aggregate fair market value of at least <span id="xdx_908_ecustom--ConditionForFutureBusinessCombinationUseOfProceedsPercentage_uPure_c20230101__20230930_zwfavMLGAwM4" title="Assets held in the Trust Account (in percentage)">80</span>% of the assets held in the Trust Account (excluding taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires <span id="xdx_908_ecustom--ConditionForFutureBusinessCombinationThresholdPercentageOwnership_uPure_c20230101__20230930_z72Ppm0T0cFi" title="Condition for future business combination threshold ownership (in percentage)">50</span>% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20211203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zosuUMc8L1R9" title="purchase price, per Unit">10.15</span> per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">The Company will proceed with a Business Combination if the Company has net tangible assets of at least $<span id="xdx_909_ecustom--ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_iI_c20230930_zrdvAY62WB47" title="Minimum of net tangible assets">5,000,001</span> either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC containing substantially the same information as would be included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the holders of the Company’s shares prior to the Initial Public Offering (the “Initial Stockholders”) have agreed (a) to vote their Founder Shares (as defined in Note 5), Private Shares (as defined in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination and (b) not to redeem any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of how or whether they vote on the proposed transaction or do not vote at all.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">The Initial Stockholders have agreed (a) to waive their redemption rights with respect to their Founder Shares, Private Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation that would affect a public stockholders’ ability to convert or sell their shares to the Company in connection with a Business Combination or affect the substance or timing of the Company’s obligation to redeem <span id="xdx_909_ecustom--PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_dp_c20230101__20230930_zYGJv2ub9ml7" title="Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)">100</span>% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">The Company will have until December 4, 2023 (unless the Company extends the period of time it has to complete an initial business combination) to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes and liquidation expenses, divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">On May 17, 2023, the Company held a special meeting of stockholders (the “Special Meeting”), at which the Company’s stockholders approved an amendment (the “Extension Amendment”) to the Amended and Restated Certificate of Incorporation to give the Company the right to extend the date by which the Company has to consummate a business combination up to six (<span id="xdx_90B_ecustom--NumberOfTimesUptoWhichBusinessCombinationIsConsummated_iI_uInteger_c20230517__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentMember_zJrkiWWFOrWk" title="Number of times up to which the business combination is consummated">6</span>) times, each such extension for an additional one (<span id="xdx_904_ecustom--AdditionalTermGivenForExtensionOfAmendment_dtM_c20230510__20230517__us-gaap--TypeOfArrangementAxis__custom--ExtensionAmendmentMember_zYqLYFwR39df" title="Period of extension amendment allowed">1</span>) month period, from June 3, 2023 to December 4, 2023. In connection with the Special Meeting stockholders exercised their right to redeem <span id="xdx_901_ecustom--StockholdersExercisedTheirRightToRedeemCommonStockNumberOfShares_c20230101__20230930_zZNKsP7XACt1" title="Number of shares exercised to redeem">8,989,488</span> shares of common stock for an aggregate price of approximately $<span id="xdx_903_ecustom--AggregatePrice_iI_c20230930_z4ZEpBE3clV9" title="Aggregate price">10.36</span> per share, for an aggregate redemption amount of $<span id="xdx_904_ecustom--StockholdersExercisedTheirRightToRedeemCommonStockValueOfShares_c20230101__20230930_zZOhiBQyzyP1" title="Value shares exercised to redeem">93,010,772</span>. After the satisfaction of such redemptions, the balance in the Company’s Trust account on June 2, 2023, was $<span id="xdx_90F_eus-gaap--AssetsHeldInTrustCurrent_iI_c20230602_zHlxOUz4onDg" title="Balance in trust account">27,077,077</span> (including interest not previously released to the Company).</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">On May 3 and 4, 2023, the Company entered into non-redemption agreements with certain stockholders owning, in the aggregate, <span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_c20230503__us-gaap--TypeOfArrangementAxis__custom--NonRedemptionAgreementsMember_pdd">2,000,000 </span>shares of the Company’s common stock (the “Non-redeeming Stockholders”), pursuant to which such stockholders agreed, among other things, not to redeem or exercise any right to redeem such public shares in connection with the Extension Amendment. In consideration of such agreements, certain of our Initial Stockholders agreed to pay the Non-redeeming Stockholders that entered into such agreements $<span id="xdx_90B_ecustom--PricePerShareAgreedToNonRedeemingShareholdersByInitialStockholders_iI_c20230503__us-gaap--TypeOfArrangementAxis__custom--NonRedemptionAgreementsMember_zbyIrSmm3kD">0.04 </span>per share for each one-month extension. On July 20, 2023, the Company entered into amendments to the non-redemption agreements to provide that the Company or certain Initial Stockholders, or their affiliates or designees, will pay such stockholders that entered into the non-redemption agreements $<span id="xdx_905_ecustom--PricePerShareAgreedToNonRedeemingShareholdersByInitialStockholders_iI_c20230720__us-gaap--TypeOfArrangementAxis__custom--NonRedemptionAgreementsMember_zETYzxZ6aWw3">0.04 </span>per share for each one-month extension in connection with such agreements. On May 30, 2023, June 29, 2023, July 31, 2023, August 31, 2023, October 2, 2023 and November 6, 2023, the Company issued payments to the Non-redeeming Stockholders in the aggregate amount of $<span id="xdx_903_ecustom--PaymentsToNonRedeemableStockholdersInRelationToExtensionOfCombination_iI_c20231106__us-gaap--TypeOfArrangementAxis__custom--NonRedemptionAgreementsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ze96duGURCs">480,000 </span>in relation to the extension of the Combination Period through December 4, 2023. The payments were presented as finance costs in the accompanying condensed statements of operations. The Company evaluated the classification and accounting of the payments to the Non-redeeming shareholders under ASC 815-40, “Derivatives and Hedging-Contracts in Entity’s Own Equity”. ASC 815-40 states that if an instrument is not considered indexed to a reporting entity’s own stock, it should be classified as an asset or liability and recorded at fair value with changes in fair value recorded in the income statement. The Company determined that as of September 30, 2023, a liability due to non-redeeming stockholders should be recorded at a fair value of $<span id="xdx_90E_ecustom--DueToNonRedeemingStockholdersCurrent_iI_c20230930_zk4EAXDJedIh" title="Due to non redeeming stockholders current">151,189 </span>and is included in the accompanying unaudited condensed balance sheets. The Company recognized $<span id="xdx_906_ecustom--IncreaseDecreaseInDueToNonRedeemingStockholders_pp0p0_c20230701__20230930_z9nNEs1JJq86" title="Due to non-redeeming stockholders">8,811 </span>of income and $<span id="xdx_90A_ecustom--IncreaseDecreaseInDueToNonRedeemingStockholders_c20230101__20230930_pp0p0" title="Due to non-redeeming stockholders">471,189</span> of expense for the fair value of due to non-redeeming shareholders in the accompanying unaudited condensed statement of operations for the three and nine months ended September 30, 2023, respectively. The Company recognized no expense for the fair value of due to non-redeeming shareholders in the accompanying unaudited condensed statement of operations for the three and nine months ended September 30, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">The Initial Stockholders have agreed to waive their liquidation rights with respect to the Founder Shares and Private Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the per share value deposited into the Trust Account ($<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_c20211203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z0Ja9qBphZP" title="purchase price, per Unit">10.15</span>).</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">In order to protect the amounts held in the Trust Account, the Initial Stockholders have agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_c20211203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp2d" title="purchase price, per Unit">10.15</span> per Public Share, except as to any claims by a third party who executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Initial Stockholders will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Initial Stockholders will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0"><b><i>Liquidity and Going Concern</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">As of September 30, 2023, the Company had $<span id="xdx_901_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20230930_z1ppCcnPeWpe" title="Operating bank account">112,941</span> in its operating bank account and a working capital deficit of $<span id="xdx_90B_ecustom--WorkingCapital_c20230101__20230930_zNXYcTuWcoBl" title="Working capital">1,926,678</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for performing due diligence on prospective target businesses, paying for travel expenditures, and structuring, negotiating, and consummating the Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">On July 26, 2023, the Company issued an unsecured promissory note in the aggregate amount of up to $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20230726__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNotesMember_zx9cmW2PKN0k" title="Aggregate amount">750,000</span> (the “Note”) to individuals or entities listed on the Note. The Note is non-interest bearing and is payable on the earlier of (i) the date on which the Company consummates an initial business combination or (ii) the date the Company liquidates if a Business Combination is not consummated. The Note will be repaid only from amounts remaining outside of the Company’s Trust Account, if any. The proceeds will be used by the Company to pay various expenses of the Company, including the extension payments, and for general corporate purposes. At September 30, 2023, there was $<span id="xdx_90B_ecustom--ProceedsFromPromissoryNoteRelatedParty_pp0p0_c20230101__20230930_zZHA3iJvUW1j" title="Proceeds from promissory note - related party">250,000</span> outstanding under the Note.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">The Company will need to raise additional capital through loans or additional investments from the Initial Stockholders or its officers, directors or their affiliates. The Initial Stockholders and the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. If an initial business combination is not consummated by the required date, there will be a mandatory liquidation and subsequent dissolution. These conditions raise substantial doubt about the Company’s ability to continue as a going concern one year from the date that these financial statements are issued. The Company plans to address this uncertainty through working capital loans and through consummation of our initial business combination. There is no assurance that working capital loans will be available to the Company or that our plans to consummate a business combination will be successful; therefore, there is substantial doubt about our ability to continue as a going concern. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0"><b><i>Risks and Uncertainties</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">The Company continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that COVID-19 could have a negative effect on the Company’s search for a target company for a Business Combination, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0"><b>Inflation Reduction Act of 2022</b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal <span id="xdx_90B_ecustom--ExciseTax_iI_dp_c20220816_zfEQJElu8C1h" title="Excise tax">1</span>% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">In connection with the stockholders’ vote at the Special Meeting, public stockholders exercised their right to redeem <span id="xdx_901_ecustom--StockholdersExercisedTheirRightToRedeemCommonStockNumberOfShares_c20230101__20230930_z7IC1y17O7Qh" title="Number of shares exercised to redeem">8,989,488</span> shares of common stock for a total of $<span id="xdx_904_ecustom--StockholdersExercisedTheirRightToRedeemCommonStockValueOfShares_c20230101__20230930_zs0dtL4w5ste" title="Value shares exercised to redeem">93,010,772</span>. Excise tax should be recognized in the period incurred, that is when the repurchase occurs. Any reduction in the tax liability due to a subsequent stock issuance, or an event giving rise to an exception, that occurs within a tax year should be recorded in the period of such stock issuance or event giving rise to an exception. As of September 30, 2023, the Company recorded $<span id="xdx_901_eus-gaap--LossContingencyEstimateOfPossibleLoss_iI_c20230930_z0GPvtPS0Lwh" title="Estimated potential excise tax liability">930,108</span> of excise tax liability calculated as <span id="xdx_907_ecustom--PercentageOfEstimatedPotentialExciseTaxLiabiliyOnSharesRedeemed_iI_c20230930_z6pGjtsTN2Bb" title="Percentage of estimated potential excise tax liabiliy on shares redeemed">1</span>% of shares redeemed on May 31, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p>
	rocl	Condition For Future Business Combination Number Of Businesses Minimum ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum	1	integer
CY2023Q3	rocl	Transaction Costs TransactionCosts	1625220	usd
CY2023Q3	rocl	Sale Of Stock Underwriting Fees SaleOfStockUnderwritingFees	1150000	usd
CY2023Q3	rocl	Sale Of Stock Other Offering Costs SaleOfStockOtherOfferingCosts	475220	usd
	rocl	Condition For Future Business Combination Use Of Proceeds Percentage ConditionForFutureBusinessCombinationUseOfProceedsPercentage	80	pure
	rocl	Condition For Future Business Combination Threshold Percentage Ownership ConditionForFutureBusinessCombinationThresholdPercentageOwnership	50	pure
CY2023Q3	rocl	Condition For Future Business Combination Threshold Net Tangible Assets ConditionForFutureBusinessCombinationThresholdNetTangibleAssets	5000001	usd
	rocl	Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination	1	pure
	rocl	Stockholders Exercised Their Right To Redeem Common Stock Number Of Shares StockholdersExercisedTheirRightToRedeemCommonStockNumberOfShares	8989488	shares
CY2023Q3	rocl	Aggregate Price AggregatePrice	10.36
	rocl	Stockholders Exercised Their Right To Redeem Common Stock Value Of Shares StockholdersExercisedTheirRightToRedeemCommonStockValueOfShares	93010772	usd
CY2023Q2	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	27077077	usd
CY2023Q3	rocl	Due To Non Redeeming Stockholders Current DueToNonRedeemingStockholdersCurrent	151189	usd
CY2023Q3	rocl	Increase Decrease In Due To Non Redeeming Stockholders IncreaseDecreaseInDueToNonRedeemingStockholders	8811	usd
	rocl	Increase Decrease In Due To Non Redeeming Stockholders IncreaseDecreaseInDueToNonRedeemingStockholders	471189	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	112941	usd
	rocl	Working Capital WorkingCapital	1926678	usd
	rocl	Proceeds From Promissory Note Related Party ProceedsFromPromissoryNoteRelatedParty	250000	usd
CY2022Q3	rocl	Excise Tax ExciseTax	0.01	pure
	rocl	Stockholders Exercised Their Right To Redeem Common Stock Number Of Shares StockholdersExercisedTheirRightToRedeemCommonStockNumberOfShares	8989488	shares
	rocl	Stockholders Exercised Their Right To Redeem Common Stock Value Of Shares StockholdersExercisedTheirRightToRedeemCommonStockValueOfShares	93010772	usd
CY2023Q3	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	930108	usd
CY2023Q3	rocl	Percentage Of Estimated Potential Excise Tax Liabiliy On Shares Redeemed PercentageOfEstimatedPotentialExciseTaxLiabiliyOnSharesRedeemed	1	pure
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zYn076fiIuHe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0"><b><i><span id="xdx_869_zmT32rhgiLv3">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p>
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	115000000	usd
CY2021	rocl	Temporaryequityissuancecosts Temporaryequityissuancecosts	1625220	usd
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	3350220	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	116725000	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	1084374	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	117809374	usd
	rocl	Temporary Equity Stock Redeemed Or Called During Period Value TemporaryEquityStockRedeemedOrCalledDuringPeriodValue	93010772	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	1792959	usd
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	26591561	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.1619	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2466	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.8211	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.4184	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5980750	shares
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-646092	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	304331	usd
	us-gaap	Net Income Loss NetIncomeLoss	156857	usd
	us-gaap	Net Income Loss NetIncomeLoss	163259	usd
CY2023Q3	rocl	Accretion Of Redeemable Common Stock To Redemption Amount AccretionOfRedeemableCommonStockToRedemptionAmount	-188932	usd
CY2022Q3	rocl	Accretion Of Redeemable Common Stock To Redemption Amount AccretionOfRedeemableCommonStockToRedemptionAmount	-369382	usd
	rocl	Accretion Of Redeemable Common Stock To Redemption Amount AccretionOfRedeemableCommonStockToRedemptionAmount	-1792959	usd
	rocl	Accretion Of Redeemable Common Stock To Redemption Amount AccretionOfRedeemableCommonStockToRedemptionAmount	-442365	usd
	rocl	Excise Taxes On Stock Redemptions ExciseTaxesOnStockRedemptions	-930108	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-835024	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-65051	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2566210	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-279106	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zeQvrpTRuau3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0"><b><i><span id="xdx_862_zaVqQnZ4ay4">Concentration of Credit Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; font-family: Times New Roman, Times, Serif; font-size: 10pt; margin-top: 0; margin-right: 0; margin-bottom: 0">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"> </p>
	rocl	Minimum Period Of Piggy Back Registration Rights MinimumPeriodOfPiggyBackRegistrationRights	P5Y
	rocl	Maximum Period Of Piggy Back Registration Rights MaximumPeriodOfPiggyBackRegistrationRights	P7Y
CY2023Q3	rocl	Aggregate Gross Proceeds Percentage AggregateGrossProceedsPercentage	0.045	pure
CY2023Q3	rocl	Business Combination Amount Of Advisory Fee Payable BusinessCombinationAmountOfAdvisoryFeePayable	5175000	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	rocl	Common Stock Right To Redeem Shares Number Of Shares CommonStockRightToRedeemSharesNumberOfShares	8989488	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3336500	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3336500	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3336500	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3336500	shares
CY2023Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2510512	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	11500000	shares
	rocl	Interest Earned On Trust Account Pay For Franchise And Tax Obligation InterestEarnedOnTrustAccountPayForFranchiseAndTaxObligation	1328243	usd
	rocl	Interest Earned On Trust Account Withdrawn For Redemption Of Shares InterestEarnedOnTrustAccountWithdrawnForRedemptionOfShares	93010772	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	1	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	2	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	3	usd

Files In Submission

Name	View Source	Status
0001829126-23-007606-index-headers.html	Edgar Link	pending
0001829126-23-007606-index.html	Edgar Link	pending
0001829126-23-007606.txt	Edgar Link	pending
0001829126-23-007606-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rocl-20230930.xsd	Edgar Link	pending
rothch5_10q.htm	Edgar Link	pending
rothch5_ex31-1.htm	Edgar Link	pending
rothch5_ex31-2.htm	Edgar Link	pending
rothch5_ex32-1.htm	Edgar Link	pending
rothch5_ex32-2.htm	Edgar Link	pending
Show.js	Edgar Link	pending
rocl-20230930_cal.xml	Edgar Link	unprocessable
rocl-20230930_def.xml	Edgar Link	unprocessable
rocl-20230930_lab.xml	Edgar Link	unprocessable
rocl-20230930_pre.xml	Edgar Link	unprocessable
rothch5_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ROCL
Roth CH Acquisition V Co Stock $rocl

2023 Q4 Form 10-Q Financial Statement

#000182912623007606 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ROCL Roth CH Acquisition V Co Stock $rocl

2023 Q4 Form 10-Q Financial Statement

#000182912623007606 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ROCL
Roth CH Acquisition V Co Stock $rocl